Driehaus Capital Management is an independent boutique investment adviser managing long-only equity and multi-asset alternative strategies.
of institutional investment experience, founded in 1982 by renowned investor Richard H. Driehaus.
The 2002 sequencing of the Human Genome revolutionized our understanding of human disease, giving us heretofore unknown information about the genetic drivers of disease and, by extension, direction on how to address it. This post will provide a snapshot of where we stand in drugging the druggable universe.
Our portfolio manager Jeff James talks with Oliver Renick on TD Ameritrade Network. View here!